Besins Healthcare has expanded its pharmaceutical operations with the acquisition of UniD Manufacturing, which specialises in long-acting drug delivery technologies.

Besins Healthcare, a global pharmaceutical company specializing in hormonal health, today announced the acquisition of UniD Manufacturing, a Belgium-based pharmaceutical development and manufacturing ...

Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news. Check out the personal finance news from the world of business including BSE ...

AbbVie Inc (NYSE:ABBV) has petitioned the U.S. Supreme Court to protect its corporate records, arguing that a lower court ruling threatens the confidentiality of attorney communications. The ...

AndroGel (testosterone gel) is prescribed to treat low testosterone levels. AndroGel’s cost may depend on your dosage and whether you have health insurance. It also may depend on the pharmacy you use ...

Androgel (testosterone) is a brand-name topical gel that’s prescribed for low testosterone due to certain medical conditions in adults. The cost of the drug with and without insurance can depend on ...

(Reuters) - Any way you look at it, AbbVie (ABBV.N), opens new tab predecessor Abbott Laboratories (ABT.N), opens new tab made a bad decision when it sued generic drug maker Perrigo (PRGO.N), opens ...

(Reuters) - Any way you look at it, AbbVie ABBV.N predecessor Abbott Laboratories ABT.N made a bad decision when it sued generic drug maker Perrigo PRGO.N in 2011, as Perrigo geared up to bring a ...

AbbVie will not be pursued any further by the US government over allegations that it used 'sham' litigation to keep competition to its AndroGel testosterone replacement product off the market. The ...

A federal appeals court on Wednesday threw out an order that had required AbbVie Inc and a partner to disgorge $448 million in profit, in antitrust litigation ...

(Reuters) - A federal appeals court on Wednesday threw out an order requiring AbbVie Inc and a partner to disgorge $448 million in profit for trying to keep generic ...